AHA Experience Scientific Sessions 2024

Experience Scientific Sessions 2024 Final Program 17 Late-Breaking Science | LBS.06 | Building on the Four Pillars: Novel Trials of Medical Therapy for Heart Failure Monday, Nov. 18 | 8:00–9:15 a.m. | Main Event I Heart Failure and Cardiomyopathies Main Event | HT.ME.07 | Health Technologies Impact on Cardiology Over the Last 100 Years and What the Future Holds Monday, Nov. 18 | 8:00–9:15 a.m. | Main Event II Health Tech Featured Science | FS.04 | Featured Science: Vascular Outcomes in the Spotlight Monday, Nov. 18 | 8:00–9:15 a.m. | S100A Vascular Medicine Late-Breaking Science | LBS.07 | Revolutionizing AF Management: Cutting-Edge Approaches Monday, Nov. 18 | 9:45–11:00 a.m. | Main Event I Electrophysiology and Arrhythmias Main Event | IN.ME.08 | Making Great Strides: Our Journey in the Treatment of Acute Myocardial Infarction Monday, Nov. 18 | 9:45–11:00 a.m. | Main Event II Interventional Treatments Main Event | CS.ME.10 | Henning Lecture Session: Non-Traditional Risk Factors & Biomarkers of Peripheral Arterial Disease Monday, Nov. 18 | 9:45–11:00 a.m. | S100A Cross Specialty Featured Science | FS.05 | Featured Science: Amyloid, Hypertrophic, and Danon Cardiomyopathies: Targeted Therapies and Specific Populations Monday, Nov. 18 | 9:45–11:00 a.m. | S103BC Heart Failure and Cardiomyopathies Late-Breaking Science: In-Depth | LBS.ID.03 | Late-Breaking Science: In-Depth With CLEAR SYNERGY Monday, Nov. 18 | 9:45–10:30 a.m. | S106A Cross Specialty Late-Breaking Science | LBS.08 | New Targets and New Treatments: Advances in Lipid Therapeutics Monday, Nov. 18 | 1:30–2:45 p.m. | Main Event I Prevention and Lifestyle Medicine Main Event | GE.ME.09 | Gene Therapy in the Cardiology Clinic: Ready for Prime Time? Monday, Nov. 18 | 1:30–2:45 p.m. | Main Event II Genetics and Genomics Featured Science | FS.06 | Featured Science: Novel Insights in Cardiovascular Interventional Outcomes Monday, Nov. 18 | 1:30–2:45 p.m. | S100A Surgery and Anesthesia Featured Science | FS.07 | Featured Science: Incretin Modulation: Is a New Standard of Care Emerging? Monday, Nov. 18 | 1:30–2:45 p.m. | S103BC Heart Failure and Cardiomyopathies Main Event | ME.CS | Closing Session: Toward the Future: The Next 100 Years in Cardiovascular Science and Medicine Monday, Nov. 18 | 3:15–4:30 p.m. | Main Event II Cross Specialty Meet the Trialist MTT.01 | Meet the Trialists: nex-Z and BPROAD* Saturday, Nov. 16 | 3:15–4:00 p.m. | Overflow Theater 2, North Building, Level 2 Cross Specialty MTT.02 | Meet the Trialist: Brain AF* Sunday, Nov. 17 | 8:00–8:30 a.m. | Overflow Theater 2, North Building, Level 2 Cross Specialty MTT.03 | Meet the Trialist: GLORIOUS* Sunday, Nov. 17 | 3:30–4:15 p.m. | Overflow Theater 2, North Building, Level 2 Cross Specialty MTT.04 | Meet the Trialist: MHYH-RCT* Monday, Nov. 18 | 8:00–8:30 a.m. | Overflow Theater 2, North Building, Level 2 Cross Specialty MTT.05 | Meet the Trialist: ZODIAC* Monday, Nov. 18 | 8:45–9:15 a.m. | Overflow Theater 2, North Building, Level 2 Cross Specialty Scan the QR code for more details on Late-Breaking Science and Featured Science sessions. *Not a CE accredited session.

RkJQdWJsaXNoZXIy MjI2NjI=